Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

BHP slashes dividend as profits fall 23% on weak iron ore price

(Sharecast News) - BHP slashed its dividend and reported a sharp fall in half-year profits as lower iron ore prices caused by weaker demand from China offset higher copper earnings. Underlying attributable profit at the world's largest miner fell 23% to $5.08bn for the six months to December 31, missing estimates of $5.39bn. The interim dividend of 50 cents a share was its lowest in eight years, down 22 cents on last year's payout.

Underlying operating earnings from iron ore fell 26% to $7.2bn, while copper profits surged 44% to $5bn on the back of higher prices.

"The overall Chinese economy has been facing some headwinds, but the commodity - the sectors that are important to BHP commodity demand - have been performing strongly for the most part, and we're starting to see some green shoots in property now as well," BHP chief executive Mike Henry told the Australian Broadcasting Corporation.

Henry said global rate cuts were expected to translate into a recovery for steel and copper demand but warned that potential trade tensions "present a risk to the recovery in developed economies and across the globe", referring to the looming threat of tariffs from US President Donald Trump.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.